• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
  • Skip to footer
  • Advertise
  • Subscribe

MassDevice

The Medical Device Business Journal — Medical Device News & Articles | MassDevice

  • Latest News
  • Technologies
    • Artificial Intelligence (AI)
    • Cardiovascular
    • Orthopedics
    • Neurological
    • Diabetes
    • Surgical Robotics
  • Business & Finance
    • Wall Street Beat
    • Earnings Reports
    • Funding Roundup
    • Mergers & Acquisitions
    • Initial Public Offering (IPO)
    • Legal News
    • Personnel Moves
    • Medtech 100 Stock Index
  • Regulatory & Compliance
    • Food & Drug Administration (FDA)
    • Recalls
    • 510(k)
    • Pre-Market Approval (PMA)
    • MDSAP
    • Clinical Trials
  • Special Content
    • Special Reports
    • In-Depth Coverage
    • DeviceTalks
  • Podcasts
    • MassDevice Fast Five
    • DeviceTalks Weekly
    • OEM Talks
      • AbbottTalks
      • Boston ScientificTalks
      • DeviceTalks AI
      • IntuitiveTalks
      • MedtechWOMEN Talks
      • MedtronicTalks
      • Neuro Innovation Talks
      • Ortho Innovation Talks
      • Structural Heart Talks
      • StrykerTalks
  • Resources
    • About MassDevice
    • DeviceTalks
    • Newsletter Signup
    • Leadership in Medtech
    • Manufacturers & Suppliers Search
    • MedTech100 Index
    • Videos
    • Webinars
    • Whitepapers
    • Voices
Home » Titan Medical debuts Sport robot assisted surgery prototype

Titan Medical debuts Sport robot assisted surgery prototype

January 21, 2016 By Brad Perriello

Titan MedicalTitan Medical (CVE:TMD) yesterday introduced the prototype of its Sport robot-assisted surgery device to investors in New York as it gears up for 1st-in-human trials this year.

Titan is chasing TransEnterix (NYSE:TRXC) in the race to challenge robot-assisted surgery’s dominant player, Intuitive Surgical (NSDQ:ISRG), and its da Vinci system. TransEnterix’s SurgiBot is expected to hit the U.S. market during the 1st half of this year; Titan’s Sport offering is anticipated for mid-2017.

Late-comers to the space include the Verb joint venture between Johnson & Johnson (NYSE:JNJ) and Google (NSDQ:GOOG) subsidiary Verily Life Sciences; a still-unnamed device from Medtronic (NYSE:MDT); and stealthy Auris Surgical Robotics, led by Intuitive founder Dr. Frederic Moll.

Leerink Partners analysts Richard Newitter and Ravi Misra wrote yesterday that Titan’s Sport prototype, the 1st and only system the company’s made thus far, seems to resemble the next-generation da Vinci Sp system Intuitive is developing. At an estimated price of $800,000 with consumables priced “more in line with traditional laparoscopic instrumentation,” Titan management told the analysts, the Sport system will undercut da Vinci.

“While early commercialization efforts would include academic institutions, we believe ultimately the company’s sales funnel could lean toward smaller community hospitals where Sport could offer a lower cost of acquisition vs. a [da Vinci],” Newitter and Misra wrote.

Titan plans to ask the FDA to approve Sport for broad indications including general facial plastic surgery from Dr. Stephen Weber.

“Our sense is that within these areas mgmt. will initially focus on: (1) in GYN – benign hysterectomy, endometrial resection; (2) in urology – partial nephrectomy; and (3) a number of general surgery procedures including colorectal, bariatrics, and hernia,” they wrote.

A patent battle with Intuitive could be in the offing, they added, noting the similarities between Sport and the da Vinci Sp.

“Regarding IP, Titan mgmt. thinks its patent portfolio will protect the technology, particularly around certain ‘automation features’ (i.e., camera positioning and supposedly a mechanism of cleaning the camera lens without having to remove the camera), though we suspect ISRG will still aggressively go after Titan given the similarities we see between dv SP and Sport,” Newitter and Misra wrote.

Intuitive is slated to announce its 4th-quarter and full-year results for 2015 today after the stock market’s close.

Filed Under: Surgical Robotics, Wall Street Beat Tagged With: Intuitive Surgical, titanmedical

More recent news

  • Aurora Spine begins first procedures with Aero lumbar fusion system
  • Caranx Medical surgical robot TaviPilot AI software wins FDA clearance
  • InspireMD launches carotid stent in U.S. after FDA approval
  • Neuros Medical raises $56M Series D to support nerve stim tech
  • CorWave reports first-in-human LVAD implant

Primary Sidebar

“md
EXPAND YOUR KNOWLEDGE AND STAY CONNECTED
Get the latest med device regulatory, business and technology news.

DeviceTalks Weekly

See More >

MEDTECH 100 Stock INDEX

Medtech 100 logo
Market Summary > Current Price
The MedTech 100 is a financial index calculated using the BIG100 companies covered in Medical Design and Outsourcing.
MDO ad

Footer

MASSDEVICE MEDICAL NETWORK

DeviceTalks
Drug Delivery Business News
Medical Design & Outsourcing
Medical Tubing + Extrusion
Drug Discovery & Development
Pharmaceutical Processing World
MedTech 100 Index
R&D World
Medical Design Sourcing

DeviceTalks Webinars, Podcasts, & Discussions

Attend our Monthly Webinars
Listen to our Weekly Podcasts
Join our DeviceTalks Tuesdays Discussion

MASSDEVICE

Subscribe to MassDevice E-Newsletter
Advertise with us
About
Contact us

Copyright © 2025 · WTWH Media LLC and its licensors. All rights reserved.
The material on this site may not be reproduced, distributed, transmitted, cached or otherwise used, except with the prior written permission of WTWH Media.

Privacy Policy